9 & 10 May 2014 | New York, NY

Register

AGENDA

Friday 9 May 2014

12:30 PM – 1:30 PM 12:30 PM – 1:30 PM

Registration & CME Sign-In

1:30 PM – 4:30 PM 1:30 PM – 4:30 PM

Opening Plenary Session

Day 1 Welcome/Opening Remarks

David L. Thomas, MD, MPH
David L. Thomas, MD, MPH

The HCV Pipeline

Ira M. Jacobson, MD, FACG
Ira M. Jacobson, MD, FACG

Management of HCV Coinfection

Susanna Naggie, MD
Susanna Naggie, MD

Pharmacology of HCV Treatment

David J. Back, PhD
David J. Back, PhD

Panel Q&A

Moderator: David L. Thomas, MD, MPH
Discussants: David J. Back, PhD,
Ira M. Jacobson, MD, FACG, Susanna Naggie, MD
Moderator: David L. Thomas, MD, MPH
Discussants: David J. Back, PhD,
Ira M. Jacobson, MD, FACG, Susanna Naggie, MD

Case Discussion Panel: HIV/HCV Coinfection

Moderator: Robert S. Klein, MD
Discussants: Susanna Naggie, MD,
Mark S. Sulkowski, MD, David L. Thomas, MD, MPH
Moderator: Robert S. Klein, MD
Discussants: Susanna Naggie, MD,
Mark S. Sulkowski, MD, David L. Thomas, MD, MPH

Day 1 Wrap-Up

Robert S. Klein, MD
Robert S. Klein, MD

Saturday 10 May 2014

7:30 AM – 8:30 AM 7:30 AM – 8:30 AM

Continental Breakfast

8:30 AM – 12:00 PM 8:30 AM – 12:00 PM

AM Plenary Session

Day 2 Opening Remarks

Robert S. Klein, MD
Robert S. Klein, MD

HCV Resistance: Principles & Practice

Stuart C. Ray, MD
Stuart C. Ray, MD

Staging Our Patients: Noninvasive Markers of Fibrosis

David L. Thomas, MD, MPH
David L. Thomas, MD, MPH

Treatment of Special Populations
(Cirrhotics, gt3, Renal Failure, Post-Transplant)

Raymond T. Chung, MD
Raymond T. Chung, MD

Panel Q&A

Moderator: John F. Reinus, MD, FACG
Discussants: Raymond T. Chung, MD,
Stuart C. Ray, MD, David L. Thomas, MD, MPH
Moderator: John F. Reinus, MD, FACG
Discussants: Raymond T. Chung, MD,
Stuart C. Ray, MD, David L. Thomas, MD, MPH

Coffee Break

Debate: Treat Everyone Now or Stratify by Disease?

Moderator: John F. Reinus, MD, FACG
Treat Disease: Paul J. Gaglio, MD
Treat Virus Now: Douglas T. Dieterich, MD, FACG
Moderator: John F. Reinus, MD, FACG
Treat Disease: Paul J. Gaglio, MD
Treat Virus Now: Douglas T. Dieterich, MD, FACG
12:00 PM – 12:20 PM 12:00 PM – 12:20 PM

Transition through Lunch Buffets

12:20 PM – 1:20 PM 12:20 PM – 1:20 PM

Parallel Lunch Case Discussions

•  Acute Infection

    Arthur Y. Kim, MD
Arthur Y. Kim, MD

•  Extrahepatic Manifestations of HCV

    Donald M. Jensen, MD
Donald M. Jensen, MD

•  Management of HCV Cirrhotics

    John F. Reinus, MD, FACG
John F. Reinus, MD, FACG
1:20 PM – 1:30 PM 1:20 PM – 1:30 PM

Transition to Plenary Session

1:30 PM – 4:30 PM 1:30 PM – 4:30 PM

PM Plenary Session

HCV Treatment Recommendations 2014:
Highlights from the AASLD-IDSA Guidelines Panel

Donald M. Jensen, MD
Donald M. Jensen, MD

Management of HCV: Cost-Effectiveness

John B. Wong, MD
John B. Wong, MD

Management of HCV: Barriers to Treatment

Mark S. Sulkowski, MD
Mark S. Sulkowski, MD

Case-Based Panel Discussion with Q&A

Moderator: Raymond T. Chung, MD
Discussants: Donald M. Jensen, MD,
Mark S. Sulkowski, MD, David L. Thomas, MD, MPH,
John B. Wong, MD
Moderator: Raymond T. Chung, MD
Discussants: Donald M. Jensen, MD,
Mark S. Sulkowski, MD, David L. Thomas, MD, MPH,
John B. Wong, MD

Day 2 Wrap-Up/Closing Remarks

John F. Reinus, MD, FACG
John F. Reinus, MD, FACG